Skip to main content

REGULACION DEL PROCESAMIENTO DE LOS CORTES DE DOBLE CADENA EN EL ADN Y SU IMPLICACION EN EL DESARROLLO TUMORAL

SAF2013-43255-P

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D (Excelencia / Generación de Conocimiento)
Call year 2013
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre UNIVERSIDAD DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

CtIP-specific roles during cell reprogramming have long-term consequences in the survival and fitness of induced pluripotent stem cells

  • Gómez-Cabello, Daniel
  • Checa-Rodríguez, Cintia
  • Abad, María
  • Serrano, Manuel
  • Huertas Sánchez, Pablo
Acquired genomic instability is one of the major concerns for the clinical use of induced pluripotent stem cells (iPSCs). All reprogramming methods are accompanied by the induction of DNA damage, of which double-strand breaks are the most cytotoxic and mutagenic. Consequently, DNA repair genes seem to be relevant for accurate reprogramming to minimize the impact of such DNA damage. Here, we reveal that reprogramming is associated with high levels of DNA end resection, a critical step in homologous recombination. Moreover, the resection factor CtIP is essential for cell reprogramming and establishment of iPSCs, probably to repair reprogramming-induced DNA damage. Our data reveal a new role for DNA end resection in maintaining genomic stability during cell reprogramming, allowing DNA repair fidelity to be retained in both human and mouse iPSCs. Moreover, we demonstrate that reprogramming in a resection-defective environment has long-term consequences on stem cell self-renewal and differentiation, This work was funded by an R + D + I grant from the Spanish Ministry of Economy and Competitivity (SAF2013-43255-P) and an ERC Starting Grant (DSBRECA)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancer

  • Rabinowicz, Noa
  • Checa-Rodríguez, Cintia
  • Huertas Sánchez, Pablo
  • Izraeli, Shai
Rabinowicz, Noa et al., Advanced ovarian cancer is an incurable disease. Thus, novel therapies are required. We wished to identify new therapeutic targets for ovarian cancer. ShRNA screen performed in 42 ovarian cancer cell lines identified the centriolar replication factor STIL as an essential gene for ovarian cancer cells. This was verified in-vivo in orthotopic human ovarian cancer mouse models. STIL depletion by administration of siRNA in neutral liposomes resulted in robust anti-tumor effect that was further enhanced in combination with cisplatin. Consistent with this finding, STIL depletion enhanced the extent of DNA double strand breaks caused by DNA damaging agents. This was associated with centrosomal depletion, ongoing genomic instability and enhanced formation of micronuclei. Interestingly, the ongoing DNA damage was not associated with reduced DNA repair. Indeed, we observed that depletion of STIL enhanced canonical homologous recombination repair and increased BRCA1 and RAD51 foci in response to DNA double strand breaks. Thus, inhibition of STIL significantly enhances the efficacy of DNA damaging chemotherapeutic drugs in treatment of ovarian cancer., This research was supported by grant OC100237 from USA Department of Defense (to S. Izraeli and A.K. Sood), by SINF (S. Izraeli and A.K. Sood), Israel Science Foundation ICORE program (S. Izraeli, A. Levy-Barda), Israel Cancer Research Foundation (N. Rabinowicz) and Israel Ministry of Science/German Cancer Research Center (S. Izraeli), Israel Ministry of Commerce “Nofar” program (SI), The Giorgio and Dora Shapiro Chair for Hematological Malignancies (SI), NIH grants (CA083639, CA098258, UH2 TR000943, and CA016672 for A.K. Sood), the RGK Foundation (A.K. Sood), the Frank McGraw Memorial Chair in Cancer Research and the American Cancer Society Research Professor Award (A.K. Sood), grants from the Regional Government of Andalucia (P12-BIO-515, P. Huertas), the Spanish Ministry of Economy and Competitivity (SAF2013-43255-P, P. Huertas) and the European Research Council (DSBRECA, P. Huertas)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Importance of hydrophobic interactions in the single-chained cationic surfactant-DNA complexation

  • López-López, Manuel
  • Checa-Rodríguez, Cintia
  • Prados-Carvajal, Rosario
  • Huertas Sánchez, Pablo
  • Moyá, María Luisa
López-López, Manuel et al., The goal of this work was to understand the key factors determining the DNA compacting capacity of single-chained cationic surfactants. Fluorescence, zeta potential, circular dichroism, gel electrophoresis and AFM measurements were carried out in order to study the condensation of the nucleic acid resulting from the formation of the surfactant-DNA complexes. The apparent equilibrium binding constant of the surfactants to the nucleic acid, K, estimated from the experimental results obtained in the ethidium bromide competitive binding experiments, can be considered directly related to the ability of a given surfactant as a DNA compacting agent. The plot of ln(K) vs. ln(cmc), cmc being the critical micelle concentration, for all the bromide and chloride surfactants studied, was found to be a reasonably good linear correlation. This result shows that hydrophobic interactions mainly control the surfactant DNA compaction efficiency., This work was financed by the Consejería de Innovación, Ciencia y Empresa de la Junta de Andalucía (P12-FQM-1105), FQM-274 and FQM-206, University of Seville (2017/1004), R+D+i grant from the Spanish Ministry of Economy and Competitivity (SAF2013-43255 and SAF2016-74855) and FEDER funds., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Multiple roles of the splicing complex SF3B in DNA end resection and homologous recombination

  • Prados-Carvajal, Rosario
  • López-Saavedra, Ana
  • Cepeda-García, Cristina
  • Jimeno, Sonia
  • Huertas Sánchez, Pablo
The appropriate repair of DNA double strand breaks is critical for genome maintenance. Thus, several cellular pathways collaborate to orchestrate a coordinated response. These include the repair of the breaks, which could be achieved by different mechanisms. A key protein involved in the regulation of the repair of broken chromosomes is CtIP. Here, we have found new partners of CtIP involved in the regulation of DNA break repair through affecting DNA end resection. We focus on the splicing complex SF3B and show that its depletion impairs DNA end resection and hampers homologous recombination. Functionally, SF3B controls CtIP function at, as least, two levels: by affecting CtIP mRNA levels and controlling CtIP recruitment to DNA breaks, in a way that requires ATM-mediated phosphorylation of SF3B2 at serine 289. Indeed, overexpression of CtIP rescues the resection defect caused by SF3B downregulation. Strikingly, other SF3B depletion phenotypes, such as impaired homologous recombination or cellular sensitivity to DNA damaging agents, are independent of CtIP levels, suggesting a more general role of SF3B in controlling the response to chromosome breaks., This work was funded by a R + D + I grant from the Spanish Ministry of Economy and Competitivity (SAF2013-43255-P) and an ERC Starting Grant (DSBRECA). AL-S is the recipient of a FPI fellowship from the Spanish Ministry of Economy and Competitivity, and RP-C is funded with an FPU fellowship from the Spanish Ministry of Education. CABIMER is supported by the regional government of Andalucia (Junta de Andalucía)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The ubiquitin E3/E4 ligase UBE4A adjusts protein ubiquitylation and accumulation at sites of DNA damage, facilitating double-strand break repair

  • Baranes-Bachar, Keren
  • Levy-Barda, Adva
  • Oehler, Judith
  • Reid, Dylan A.
  • Soria-Bretones, Isabel
  • Voss, Ty C.
  • Chung, Dudley
  • Park, Yoon
  • Liu, Chao
  • Yoon, Jong-Bok
  • Li, Wei
  • Dellaire, Graham
  • Misteli, Tom
  • Huertas Sánchez, Pablo
  • Rothenberg, Eli
  • Ramadan, Kristijan
  • Ziv, Yael
  • Shiloh, Yosef
Double-strand breaks (DSBs) are critical DNA lesions that robustly activate the elaborate DNA damage response (DDR) network. We identified a critical player in DDR fine-tuning: the E3/E4 ubiquitin ligase UBE4A. UBE4A’s recruitment to sites of DNA damage is dependent on primary E3 ligases in the DDR and promotes enhancement and sustainment of K48- and K63-linked ubiquitin chains at these sites. This step is required for timely recruitment of the RAP80 and BRCA1 proteins and proper organization of RAP80- and BRCA1-associated protein complexes at DSB sites. This pathway is essential for optimal end resection at DSBs, and its abrogation leads to upregulation of the highly mutagenic alternative end-joining repair at the expense of error-free homologous recombination repair. Our data uncover a critical regulatory level in the DSB response and underscore the importance of fine-tuning the complex DDR network for accurate and balanced execution of DSB repair., Work in the Y.S. laboratory is funded by research grants from the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, the A-T Children’s Project, the Israel Science Foundation Joint ISF-NSFC Research Program (jointly funded by the Israel Science Foundation and the National Natural Science Foundation of China - Grant No. 998/14), and the Israel Cancer Research Fund (Professorship). T.M. and T.C.V. were supported by funding from the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, and the Center for Cancer Research. Work in the K.R. laboratory is supported by the Swiss National Science Foundation (31003A_141197) and the Medical Research Council, UK (MC_PC_12001/1). Work in the G.D. laboratory is supported by a discovery grant from the Natural Sciences and Engineering Research Council of Canada (RGPIN 05616). Work in the P.H. lab was supported by an R+D+I grant from the Spanish Ministry of Economy and Competitivity (SAF2013-43255-P) and an ERC starting grant (DSBRECA). Work in the E.R. laboratory is supported by NIH grants GM108119 and CA187612 and American Cancer Society grant ACS130304-RSG-16-241-01-DMC. I.S.-B. is the recipient of a Ph.D. fellowship from the University of Sevilla. D.C. was supported by a Nova Scotia graduate scholarship. K.B.B. is a Jack and Florence Berlin fellow. Y.S. is a Research Professor of the Israel Cancer Research Fund., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Nuclear poly(A)-binding protein 1 is an ATM target and essential for DNA double-strand break repair

  • Gavish-Izakson, Michal
  • Velpula, Bhagya Bhavana
  • Elkon, Ran
  • Prados-Carvajal, Rosario
  • Barnabas, Georgina D.
  • Pineiro Ugalde, Alejandro
  • Agami, Reuven
  • Geiger, Tamar
  • Huertas Sánchez, Pablo
  • Ziv, Yael
  • Shiloh, Yosef
The DNA damage response (DDR) is an extensive signaling network that is robustly mobilized by DNA double-strand breaks (DSBs). The primary transducer of the DSB response is the protein kinase, ataxia-telangiectasia, mutated (ATM). Here, we establish nuclear poly(A)-binding protein 1 (PABPN1) as a novel target of ATM and a crucial player in the DSB response. PABPN1 usually functions in regulation of RNA processing and stability. We establish that PABPN1 is recruited to the DDR as a critical regulator of DSB repair. A portion of PABPN1 relocalizes to DSB sites and is phosphorylated on Ser95 in an ATM-dependent manner. PABPN1 depletion sensitizes cells to DSB-inducing agents and prolongs the DSB-induced G2/M cell-cycle arrest, and DSB repair is hampered by PABPN1 depletion or elimination of its phosphorylation site. PABPN1 is required for optimal DSB repair via both nonhomologous end-joining (NHEJ) and homologous recombination repair (HRR), and specifically is essential for efficient DNA-end resection, an initial, key step in HRR. Using mass spectrometry analysis, we capture DNA damage-induced interactions of phospho-PABPN1, including well-established DDR players as well as other RNA metabolizing proteins. Our results uncover a novel ATM-dependent axis in the rapidly growing interface between RNA metabolism and the DDR, Work in Y.S. laboratory is funded by research grants from the Dr Miriam and Sheldon G. Adelson Medical Research Foundation; The A-T Children's Project; The Israel Science Foundation (Joint ISF-NSFC Program with the National Natural Science Foundation of China); The Israel Cancer Research Fund; Work in P.H. lab was supported by R+D+I grant from the Spanish Ministry of Economy and Competitivity [SAF2013-43255-P]; ERC Starting Grant [DSBRECA]; PhD fellowship from the Spanish Ministry of Education (FPU to R.P.-C.); The R.A. lab is supported by NWO grant [NGI 93512001 to R.A.]; The Human Frontier Science Program [LT000640/2013 to A.P.U.]; The work in T.G. lab was supported by The I-CORE Program of the Planning and Budgeting Committee of the Israel Ministry of Education; Y.S. is a Research Professor of the Israel Cancer Research Fund. Funding for open access charge: research grant money., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive Tumors

  • Jachimowicz, Ron D.
  • Beleggia, Filippo
  • Isensee, Jörg
  • Velpula, Bhagya Bhavana
  • Goergens, Jonas
  • Bustos, Matias A.
  • Doll, Markus A.
  • Shenoy, Anjana
  • Checa-Rodríguez, Cintia
  • Wiederstein, Janica Lea
  • Baranes-Bachar, Keren
  • Bartenhagen, Christoph
  • Hertwig, Falk
  • Teper, Nizan
  • Nishi, Tomohiko
  • Schmitt, Anna
  • Distelmaier, Felix
  • Lüdecke, Hermann-Josef
  • Albrecht, Beate
  • Krüger, Markus
  • Schumacher, Björn
  • Geiger, Tamar
  • Hoon, Dave S.B.
  • Huertas Sánchez, Pablo
  • Fischer, Matthias
  • Hucho, Tim
  • Peifer, Martin
  • Ziv, Yael
  • Reinhardt, H. Christian
  • Wieczorek, Dagmar
  • Shiloh, Yosef
Genomic instability can be a hallmark of both human genetic disease and cancer. We identify a deleterious UBQLN4 mutation in families with an autosomal recessive syndrome reminiscent of genome instability disorders. UBQLN4 deficiency leads to increased sensitivity to genotoxic stress and delayed DNA double-strand break (DSB) repair. The proteasomal shuttle factor UBQLN4 is phosphorylated by ATM and interacts with ubiquitylated MRE11 to mediate early steps of homologous recombination-mediated DSB repair (HRR). Loss of UBQLN4 leads to chromatin retention of MRE11, promoting non-physiological HRR activity in vitro and in vivo. Conversely, UBQLN4 overexpression represses HRR and favors non-homologous end joining. Moreover, we find UBQLN4 overexpressed in aggressive tumors. In line with an HRR defect in these tumors, UBQLN4 overexpression is associated with PARP1 inhibitor sensitivity. UBQLN4 therefore curtails HRR activity through removal of MRE11 from damaged chromatin and thus offers a therapeutic window for PARP1 inhibitor treatment in UBQLN4-overexpressing tumors.Control of MRE11 association with chromatin by UBQLN4 during double-strand break repair influences repair pathway choice and can be dysregulated in tumorigenesis., This work was funded through the Dr. M. and S.G. Adelson Medical Research Foundation, The Israel Science Foundation joint ISF-NSFC Research Program and The Israel Cancer Research Fund (to Y.S.), the German-Israeli Foundation for Research and Development (I-65-412.20-2016 to Y.S. and H.C.R.), the Deutsche Forschungsgemeinschaft (KFO-286-RP2 to H.C.R., KFO-286-CP2 to M.P., JA2439/1-1 to R.D.J., DI1731/2-1 to F.D.), the Else Kröner-Fresenius Stiftung (2014-A06 to H.C.R., 2016_Kolleg.19 to R.D.J.), the Deutsche Krebshilfe (1117240 to H.C.R. and the Mildred-Scheel Professorship to M.P.), the German Ministry of Education and Research (BMBF 01GM1211B to D.W., BMBF e:Med 01ZX1303A and 01ZX1406 to M.P., BMBF e:Med 01ZX1303 and 01ZX1307 to M.F.), and R+D+I grants from the Spanish Ministry of Economy and Competitivity (SAF2013-43255-P and SAF2016-74855-P to P.H.). Y.S. is a Research Professor of the Israel Cancer Research Fund.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Methylation of the central transcriptional regulator KLF4 by PRMT5 is required for DNA end resection and recombination

  • Checa-Rodríguez, Cintia
  • Cepeda-García, Cristina
  • Ramón, Javier
  • López-Saavedra, Ana
  • Balestra, Fernando R.
  • Domínguez-Sánchez, María S.
  • Gómez-Cabello, Daniel
  • Huertas Sánchez, Pablo
Cell fitness and survival upon exposure to DNA damage depends on the repair of DNA lesions. Interestingly, cellular identity does affect and finetunes such response, although the molecular basis of such differences between tissues and cell types is not well understood. Thus, a possibility is that DNA repair itself is controlled by the mechanisms that govern cell identity. Here we show that the KLF4, involved in cellular homeostasis, proliferation, cell reprogramming and cancer development, directly regulates resection and homologous recombination proficiency. Indeed, resection efficiency follows KLF4 protein levels, i.e. decreases upon KLF4 downregulation and increases when is overexpressed. Moreover, KLF4 role in resection requires its methylation by the methyl-transferase PRMT5. Thus, PRMT5 depletion not only mimics KLF4 downregulation, but also showed an epistatic genetic relationship. Our data support a model in which the methylation of KLF4 by PRMT5 is a priming event required to license DNA resection and homologous recombination., This work was funded by R+D+I grants from the Spanish Ministry of Economy and Competitivity (SAF2013-43255-P, SAF2016-74855-P). FR-B is funded by the University of Sevillathrough a postdoctoral contract of the V PPIT-US. CABIMER is supported by the regional government of Andalucia (Junta de Andalucía)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Tesis doctoral (DoctoralThesis)

Crosstalk between DNA end resection and RNA metabolism

  • Prados-Carvajal, Rosario
Tesis llevada a cabo para conseguir el grado de Doctor por la Universidad de Sevilla.--2020-01-23, [EN] DNA suffers thousands of lesions from exogenous and endogenous sources. Nevertheless, double-strand breaks (DSBs) are the most dangerous form of DNA damage because if they are not properly repaired they can lead to mutations and genomic instability. In order to repair them, cells have developed two major pathways: Homologous Recombination and Non-Homologous End-Joining. CtIP is a key protein in this response since it promotes faithful repair of DSBs by licensing homologous recombination. Recently, a crosstalk between DNA Damage Response (DDR) and RNA metabolism at different levels has been discovered. Thus, in this Thesis we studied this relationship deeply. We described that the splicing complex SF3B is involved in in DNA damage repair. Although part of such function is through CtIP, we observed that SF3B plays additional roles in DNA double strand break repair that are independent of its functional relationship with this factor. Additionally, we demonstrated that this relationship is bidirectional, since CtIP is involved in DNA damage-dependent and independent alternative mRNA splicing of several genes. The careful study of the CtIPdependent splicing of one of those genes, the one that codes the helicase PIF1, suggest that those events are important for the fine tuning of the DNA damage response. Furthermore, we reported a crosstalk between the DDR and RNA editing. RNA editing is, indeed, upregulated upon exposure to DNA damage in a fashion that requires CtIP and the checkpoint kinase ATR. Moreover, our data agree with the idea that the RNA editing enzymes ADARs have a role in the removal of DNA:RNA hybrids that facilitates DSB repair., [ES] El ADN sufre muchísimos tipos de daño debido a fuentes externas o internas. No obstante, los cortes de doble cadena son de los más peligrosos porque si no se reparan adecuadamente, pueden conducir a mutaciones e inestabilidad genómica. Para reparar este daño, las células han desarrollado principalmente dos vías: la recombinación homóloga o la unión de extremos no homólogos. CtIP es una proteína clave en esta respuesta al daño porque activa la reparación de los cortes de doble cadena vía recombinación homóloga. Recientemente se ha descrito una conexión a diferentes niveles entre la respuesta al daño en el ADN (DDR por sus siglas en inglés) y el metabolismo del ARN. Por eso, en esta Tesis hemos estudiado dicha relación en profundidad. Descubrimos que el complejo de procesamiento de intrones denominado SF3B está involucrado en la reparación del daño del ADN. Aunque parte de las funciones que realiza en este proceso son a través de CtIP, también hemos demostrado que SF3B tiene otro papel independiente de su relacional funcional con esta proteína. Además, hemos comprobamos que esta relación es bidireccional, ya que CtIP también esta involucrado en el procesamiento alternativo de intrones de numerosos genes, tanto de manera constitutiva como en respuesta a la presencia de daño en el ADN. El estudio cuidadoso del la maduración de intrones dependiente de CtIP de uno de esos genes, el que codifica la helicasa PIF1, sugiere que estos eventos permiten el ajuste fino de la respuesta al daño en el ADN. Asimismo, pudimos observar una interrelación entre la DRR y el proceso de edición del ARN. La edición del ARN, de hecho, aumenta como respuesta a la presencia de daño en el ADN en un proceso regulado por CtIP y la quinasa ATR. Además, nuestros datos están de acuerdo con la idea de que las proteínas de edición de ARN ADARs juegan un papel en la disolución de híbridos de ADN:ARN que facilita la reparación de cortes de doble cadena en el ADN., I did this work thanks to receiving a FPU fellowship from the Spanish Ministry of Education (FPU. Additionally, these projects were funded by two R+D+I grants from the Spanish Ministry of Economy and Competitivity (SAF2013-43255-P and SAF2016- 74855-P) and a Starting Grant from the European Research Council (DSBRECA).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The COP9 signalosome is vital for timely repair of DNA double-strand breaks

  • Meir, Michal
  • Galanty, Yaron
  • Kashani, Lior
  • Blank, Michael
  • Khosravi, Rami
  • Fernández-Ávila, María Jesús
  • Cruz-García, Andrés
  • Star, Ayelet
  • Shochot, Lea
  • Thomas, Yann
  • Garrett, Lisa J.
  • Chamovitz, Daniel A.
  • Bodine, David M.
  • Kurz, Thimo
  • Huertas, Pablo
  • Ziv, Yael
  • Shiloh, Yosef
The DNA damage response is vigorously activated by DNA double-strand breaks (DSBs). The chief mobilizer of the DSB response is the ATM protein kinase. We discovered that the COP9 signalosome (CSN) is a crucial player in the DSB response and an ATM target. CSN is a protein complex that regulates the activity of cullin ring ubiquitin ligase (CRL) complexes by removing the ubiquitin-like protein, NEDD8, from their cullin scaffold. We find that the CSN is physically recruited to DSB sites in a neddylation-dependent manner, and is required for timely repair of DSBs, affecting the balance between the two major DSB repair pathways-nonhomologous end-joining and homologous recombination repair (HRR). The CSN is essential for the processivity of deep end-resection-the initial step in HRR. Cullin 4a (CUL4A) is recruited to DSB sites in a CSN- and neddylation-dependent manner, suggesting that CSN partners with CRL4 in this pathway. Furthermore, we found that ATM-mediated phosphorylation of CSN subunit 3 on S410 is critical for proper DSB repair, and that loss of this phosphorylation site alone is sufficient to cause a DDR deficiency phenotype in the mouse. This novel branch of the DSB response thus significantly affects genome stability., Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Israel Cancer Research Fund; Israel Science Foundation (grants no. 1900/12 and 998/14); The I-CORE Program of the Planning and Budgeting Committee of the Israel Ministry of Education, to YS laboratory; Spanish Ministry of Economy and Competitivity ( SAF2013-43255-P) and ERC Starting Grant (DSBRECA), to PH laboratory; ERC Starting Grant (NEDD8andCRLs) to TK laboratory; Consejo Nacional de Ciencia y Tecnología (CONACYT), Mexico, to A.C.-G. YS is a Research Professor of the Israel Cancer Research Fund. Funding for open access charge: Donation to our lab., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

DNA topoisomerase IIß inhibition blocks DNA end resection and synergizes with PARPi in BRCA1-deficient models

  • Camarillo, Rosa
  • Prados-Carvajal, Rosario
  • Cruz-García, Andrés
  • Rodríguez-Real, Guillermo
  • Herencia-Ropero, Andrea
  • Serra, Violeta
  • Jimeno, Sonia
  • Huertas Sánchez, Pablo
DNA end resection is a critical step that governs how a broken chromosome will be repaired. As such, it is heavily regulated by multiple cellular signals and processes. Alterations in the regulation of DNA end resection have consequences for cell survival upon exposure to cytotoxic agents, including those used during cancer chemotherapy. Here, we identified several small molecules that affect the process of DNA end resection. Among them, we focus on determining the mode of action of merbarone, a DNA topoisomerase II inhibitor. We uncover a role of the topoisomerase IIβ isoform in the full processing of DNA breaks. Moreover, we show that the effect of merbarone is affected by the formation of G4 quadruplexes and that BRCA1-deficient cancer cells are sensitive to merbarone. Strikingly, this sensitivity can be partially suppressed in cell lines expressing hypomorphic versions of BRCA1 lacking exon 11, a hypomorph that has been linked to PARPi-resistance. Using cellular models, we show that PARPi- and merbarone-resistant BRCA1 exon 11 mutant cells, but not wildtype BRCA1 cells, are sensitive to the combination of both drugs. Finally, we show that combination of merbarone and the PARPi olaparib has a mild antitumor effect in a PARPi-resistant PDX model bearing a BRCA1 exon 11 mutation., This work was funded by the R+D+I grants SAF2013-43255-P, SAF2016-74855-P, PID2019-104195G and PID2022-136791NB-I00 funded by MICIU/AEI/10.13039/501100011033/ FEDER/UE to P.H., and grants PID2022-140603NB-I00 funded by MICIU/AEI/10.13039/501100011033/ FEDER/UE and the Ideas Semilla Project IDEAS222767JIME from the Asociación Española Contra el Cáncer (AECC) to S.J and the SINERGIA project SNRGS247052PRAD from AECC to RP-C. RC-D was funded with an FPI fellowship from the Spanish Ministry of Economy and Competitivity. RP-C was funded with an FPU fellowship from the Spanish Ministry of Education and a Postdoctoral Fellowship from the Asociación Española Contra el Cáncer (AECC). AC-G was supported by the Government of Mexico with a fellowship of the CONACYT. CABIMER is supported by the Regional Government of Andalucía (Junta de Andalucía). V.S. received funds from the Instituto de Salud Carlos III (ISCIII), an initiative of the Spanish Ministry of Economy and Innovation partially supported by European Regional Development FEDER Funds (PI20/00892 and CPII19/00033). AH-R received funding from Generalitat de Catalunya (PERIS SLT017/20/000081). P. Huertas and R. Prados-Carvajal disclose non-financial support from AstraZeneca. Additionally, V. Serra reports research grants from AstraZeneca and personal fees and/or nonfinancial support from AstraZeneca and GSK., Peer reviewed